Editorial Advisory Board Spotlight: Susan J. Schniepp
Susan J. Schniepp, member of the editorial advisory boards for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International, provides an update on her experience working in the pharmaceutical industry and what she sees for the industry’s future.
Susan J. Schniepp
The PharmTech Group’s Editorial Advisory Boards (EABs) provide our editors with expert insights into the development, manufacturing, and quality issues impacting the bio/pharmaceutical industry. EAB members offer valuable input to our editors by reviewing editorial submissions and advising on relevant topics for the magazines and our websites.
This Editorial Advisory Board Spotlight features Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, a Nelson Labs company. Susan has been a member of the EAB for several years and a regular contributor to our Ask the Expert print and video series. Susan has offered thought leadership and expert insight into quality and regulatory concerns for our publications. She has also served as the past-chair of the Parenteral Drug Association and was previously a chair with the US Pharmacopeia.
Click the video above to learn more about Susan and her views on the industry.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
3D Screen Printing: Enabling A New Generation of Complex Formulations
April 14th 20253D screen printing provides innovative drug development capabilities that are difficult or impossible to achieve with traditional methods, including complex multi-layered formulations, precision control over drug release profiles, and near-endless possibilities in the geometric shaping of dosage forms. In this article, learn how 3D screen printing offers unmatched flexibility to tailor formulations for specific therapeutic needs and redefines what’s possible in drug development and manufacturing.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
